Padronização e validação de técnica de qPCR para detecção dos HPVs de alto risco 16 e 18 em pacientes com doença inflamatória intestinal
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
The Human papillomaviruses (HPVs) are double-stranded DNA viruses with great
genetic diversity cause skin and mucous membrane infections. Some of the virus’ types
are linked to several forms of cancer, such as cervical and anal cancers, with the types
16 and 18 being the most common. However, data on the prevalence of anal HPV
infection are scarce, and data on anal infection in patients with inflammatory bowel
disease (IBD), such as Crohn's disease and ulcerative colitis, are even scarcer. This
population may be at special risk due to constant inflammation, atypical immune response,
and frequent use of immunosuppressive drugs, which are known to be associated with
the development of neoplasia. This highlights the importance of detecting HPV in this
population. HPV infection can occur even in the absence of detectable lesions, and
molecular techniques such as PCR are remarkably useful in identifying the pathogen and
differentiating its types. Therefore, the objective of this study is to standardize a
quantitative PCR (qPCR) reaction for the detection of HPV 16 and 18, and to validate the
protocol in clinical samples from patients with IBD. For standardization, variations in the
concentration of primers and probes, thermal cycling conditions, as well as other qPCR
parameters were tested, in addition to in silico tests of the primers and probes. Quantified
samples known to be positive for HPV types 16 and 18 were used to construct a standard
concentration curve in order to evaluate parameters related to the performance of the
assay, such as the efficiency, sensitivity and linearity of the reaction. Different commercial
DNA extraction kits were tested in order to select the most suitable one for the samples
used. To this end, the genetic material extracted from two samples was quantified and
assessed for its purity. After the reaction was standardized, samples collected from 183
patients, 133 with IBD and 50 healthy patients (control group) were used for validation.
The best DNA extraction result was achieved using the Qiaamp DNA blood mini kit
(Quiagen). Specificity tests showed that the primers were specific for both the types
tested. The sensitivity of the reaction for detecting HPV 16 and 18 is up to 10 copies/µL.
The efficiency and r² calculated for the HPV 16 detection reaction were 92.032 and 0.985,
respectively. For the HPV 18 detection reaction, the efficiency was 93.055 and the r² was
0.986. Of the 183 samples used, 9 were positive for some type of HPV, 2 from the control
group and 7 from the IBD group. However, the difference between the two groups was
not significant (p>0.05). Finally, it should be emphasized that it is important to generate
more data on HPV infection in patients with IBD, so that better prophylactic measures and
health guidelines can be developed for this population.
Description
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

